Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

BD and Hamilton Join Forces to Automate Single-Cell Multiomics Research

NextEdge Admin

28 Jan 2024

2 min 9 sec

Hamilton Join Forces,single-cell multiomics

Becton Dickinson (BD) revealed a new collaboration with laboratory robotics developer Hamilton, focusing on the creation of automated solutions for single cell multiomics research. The joint effort aims to introduce applications in phases, commencing in 2024, although the financial details of the agreement remain undisclosed.

Within this partnership, BD will design reagent kits compatible with the Hamilton Microlab NGS STAR robotic liquid-handling platform, specifically tailored for its BD Rhapsody Single-Cell Analysis Library Preparation line. This combined solution is set to automate the crucial steps of pipetting and thermal cycling, streamlining the production of DNA libraries prepared for genetic sequencing, as stated by BD.

Steve Conly, worldwide president at BD Biosciences, emphasized the significance of integrating Hamilton’s robotic technology into their single-cell multiomics solutions. This move is aimed at enhancing automation to empower researchers across academia, biopharmaceuticals, and contract research organizations, facilitating larger-scale single-cell multiomics studies with increased confidence.

In a corresponding statement, Matt Hamilton, vice CEO at Hamilton, outlined their shared objective to provide a comprehensive solution that minimizes potential biases, enabling higher throughput. The goal is to empower laboratories to achieve more reliable results in their research endeavors.

It’s worth noting that Hamilton has recently engaged in a similar collaboration with Pacific Biosciences, focusing on automated library preparation solutions for the NGS STAR system.